MBL2 and lung cancer: Moreover, an early postoperative reduction in MBL, CL-L1, H-ficolin, M-ficolin, MASP-3, MAp44, MASP-2, and MAp19, but not MASP-1, was recently reported in lung cancer patients undergoing thoracoscopic lobectomy [41].